Pencil Biosciences is a novel gene modulation company.
Pencil Biosciences has raised $6.8M in total funding. The most recent round was Seed. The last funding was announced in September 2023.
Pencil Biosciences's investors include Octopus Ventures, Northern Gritstone, Future Planet Capital, SyndicateRoom, Catapult Ventures.
Pencil Biosciences is headquartered in Alderley Park, United Kingdom.
Pencil Biosciences is a novel gene modulation company.
Pencil Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pencil Biosciences — Funding & Investors." VCBacked, September 28, 2023, https://www.vcbacked.co/company/pencil-biosciences. Accessed October 17, 2026.
VCBacked. (2023). Pencil Biosciences — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/pencil-biosciences
{{cite web |title=Pencil Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/pencil-biosciences |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated